| Peter B Blessey, MD | |
|
2750 Gause Blvd E, Slidell, LA 70461-4149 | |
| (985) 639-3777 | |
| Not Available |
| Full Name | Peter B Blessey |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 28 Years |
| Location | 2750 Gause Blvd E, Slidell, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467488163 | NPI | - | NPPES |
| 00126698 | Medicaid | MS | |
| 1140589 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD.14786R (Louisiana) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | MD.14786R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pulse Home Health Care | Covington, LA | Home health agency |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| St Tammany Parish Hospital | Covington, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced today that it has reached an agreement with the U.S. Food and Drug Administration under a special protocol assessment for a global pivotal Phase 3 trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have relapsed or were refractory following prior treatment with chemotherapy.
WebMD Health Corp., the leading source of health information, today announced its 2010 Year in Health, which represents the health stories, searches, questions and trends that WebMD's audience of more than 83 million monthly visitors sought from the company's websites, mobile applications and communities during the year.
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis, a potentially deadly blood clotting condition.
A new technique devised by researchers from North Carolina State University and the University of Calgary provides a more in-depth look at the metabolism and physiology within microbial communities - the microscopic life such as bacteria, viruses and other tiny forms of life within our bodies and throughout nature.
Wounded Warrior Project will provide $45 million to Rush University Medical Center to substantially grow its Road Home Program, allowing an expected 5,000 military veterans or their family members to receive mental health care services without cost to them over the next five years.
› Verified 2 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced today that it has reached an agreement with the U.S. Food and Drug Administration under a special protocol assessment for a global pivotal Phase 3 trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have relapsed or were refractory following prior treatment with chemotherapy.
WebMD Health Corp., the leading source of health information, today announced its 2010 Year in Health, which represents the health stories, searches, questions and trends that WebMD's audience of more than 83 million monthly visitors sought from the company's websites, mobile applications and communities during the year.
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis, a potentially deadly blood clotting condition.
A new technique devised by researchers from North Carolina State University and the University of Calgary provides a more in-depth look at the metabolism and physiology within microbial communities - the microscopic life such as bacteria, viruses and other tiny forms of life within our bodies and throughout nature.
Wounded Warrior Project will provide $45 million to Rush University Medical Center to substantially grow its Road Home Program, allowing an expected 5,000 military veterans or their family members to receive mental health care services without cost to them over the next five years.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter B Blessey, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Peter B Blessey, MD 2750 Gause Blvd E, Slidell, LA 70461-4149 Ph: (985) 639-3777 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced today that it has reached an agreement with the U.S. Food and Drug Administration under a special protocol assessment for a global pivotal Phase 3 trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have relapsed or were refractory following prior treatment with chemotherapy.
WebMD Health Corp., the leading source of health information, today announced its 2010 Year in Health, which represents the health stories, searches, questions and trends that WebMD's audience of more than 83 million monthly visitors sought from the company's websites, mobile applications and communities during the year.
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis, a potentially deadly blood clotting condition.
A new technique devised by researchers from North Carolina State University and the University of Calgary provides a more in-depth look at the metabolism and physiology within microbial communities - the microscopic life such as bacteria, viruses and other tiny forms of life within our bodies and throughout nature.
Wounded Warrior Project will provide $45 million to Rush University Medical Center to substantially grow its Road Home Program, allowing an expected 5,000 military veterans or their family members to receive mental health care services without cost to them over the next five years.
› Verified 2 days ago
Dr. John Allen Davis Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 995 Robert Blvd, Slidell, LA 70458 Phone: 985-520-0909 | |
Frederick L Keppel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1051 Gause Blvd, Suite 230, Slidell, LA 70458 Phone: 985-280-9855 Fax: 985-280-3683 | |
Dr. Charles W Krieger Jr., MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1051 Gause Blvd, Suite 230, Slidell, LA 70458 Phone: 985-280-3664 Fax: 985-280-3683 | |
Alexander Habashy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 104 Medical Center Dr, Slidell, LA 70461 Phone: 985-646-5550 Fax: 985-646-5560 | |
Brian Thomas Kindl, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1810 Lindberg Dr Ste 1400, Slidell, LA 70458 Phone: 985-326-8614 | |
Dr. Simon Finger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1150 Robert Blvd, Suite 240, Slidell, LA 70458 Phone: 985-646-3662 Fax: 985-646-3691 |